A vaccine for respiratory syncytial virus (RSV) is now available for older Canadians, but experts worry that cost of the vaccine could be a barrier to seniors and could lead to preventable hospitalizations — and potentially, death.
Health
Cost of RSV vaccine a barrier to older Canadians amid respiratory season, experts warn
More Videos
-
Upgrading Ontario’s 911 Emergency Response System
-
Baby cereal brand recalled across Canada over Cronobacter concerns
-
Health Matters: Canadian Food Inspection Agency triggers recall for Baby Gourmet cereal
-
‘Homemade sunscreen use risky’: Health Canada
-
The TikTok Health Hazard: Misinformation’s impact on Gen Z
-
CrowdStrike outage impacting hospitals, health care systems across Canada
You are viewing an Accelerated Mobile Webpage.
View Original Article